section name header

Indications

REMS

Unlabeled Use:

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

GI: gastric irritation (oral use only), nausea, vomiting.

Interactions

Drug-Drug:

Drug-Food:

Availability

(Generic available)

Route/Dosage

see Calculator

RDA = 15 mg. Doses expressed in mg of elemental zinc unless otherwise noted. Zinc sulfate contains 23% zinc

Deficiency

IV Nutritional Supplementation—Metabolically Stable Patients

US Brand Names

Orazinc, Zinc 220

Action

Therapeutic Effects:

Classifications

Therapeutic Classification: mineral and electrolyte replacements/supplements

Pharmacologic Classification: trace metals

Pharmacokinetics

Absorption: Poorly absorbed from the GI tract (20–30%).

Distribution: Widely distributed. Concentrates in muscle, bone, skin, kidney, liver, pancreas, retina, prostate, RBCs, and WBCs.

Metabolism/Excretion: 90% excreted in feces, remainder lost in urine and sweat.

Half-life: Unknown.

Time/Action Profile

(blood levels)

ROUTEONSETPEAKDURATION
POunknown2 hrunknown
IVunknownunknownunknown

Patient/Family Teaching

Pronunciation

zink SUL-fate audio

Code

NDC Code*